News | May 20, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
CRL shall invest another Rs. 200 crore for creation of additional beds
CRL shall invest another Rs. 200 crore for creation of additional beds
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
She has held senior positions at Coca-Cola in China and PepsiCo in India
Net Profit increased by 15% to Rs. 146 crores in Q4 FY25 and 19% to Rs. 660 crores in FY25
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Investment demonstrates confidence in America’s commitment to science and innovation
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Subscribe To Our Newsletter & Stay Updated
